Jason Aryeh, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 32,000 shares at $107.58 ($3.4M) on 2017-02-28, disclosed to the SEC on 2017-02-28.
Open-market sale of $3.4M LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.00 | 25,000 | $2.6M | 77.9% |
| 2 | $107.58 | 7,000 | $753K | 22.1% |
| Total | $106.35 avg | 32,000 | $3.4M | 100% |
| Filing → |
| OBIO | BUY | 2026-05-19 | $35K | — | Filing → |
| LGND | SELL | 2025-09-24 | $3.4M | — | Filing → |
| OBIO | BUY | 2025-09-19 | $2K | — | Filing → |